| First Author | Li JY | Year | 2012 |
| Journal | Blood | Volume | 120 |
| Issue | 22 | Pages | 4352-62 |
| PubMed ID | 22955916 | Mgi Jnum | J:193219 |
| Mgi Id | MGI:5467910 | Doi | 10.1182/blood-2012-06-438531 |
| Citation | Li JY, et al. (2012) PTH expands short-term murine hemopoietic stem cells through T cells. Blood 120(22):4352-62 |
| abstractText | Intermittent parathyroid hormone (iPTH) treatment expands hemopoietic stem and progenitor cells (HSPCs), but the involved mechanisms and the affected HSPC populations are mostly unknown. Here we show that T cells are required for iPTH to expand short-term HSPCs (ST-HSPCs) and improve blood cell engraftment and host survival after BM transplantation. Silencing of PTH/PTH-related protein receptor (PPR) in T cells abrogates the effects of iPTH, thus demonstrating a requirement for direct PPR signaling in T cells. Mechanistically, iPTH expands ST-HSPCs by activating Wnt signaling in HSPCs and stromal cells (SCs) through T-cell production of the Wnt ligand Wnt10b. Attesting to the relevance of Wnt10b, iPTH fails to expand ST-HSPCs in mice with Wnt10b(-/-) T cells. Moreover, iPTH fails to promote engraftment and survival after BM transplantation in Wnt10b null mice. In summary, direct PPR signaling in T cells and the resulting production of Wnt10b play a pivotal role in the mechanism by which iPTH expands ST-HSPCs. The data suggest that T cells may provide pharmacologic targets for HSPC expansion. |
